Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies Cash Flow Statement

Financials in millions ZAR. Fiscal year is March - February.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Net Income	978.89	1,180	984.48	1,000	853.45
Depreciation & Amortization	1,154	1,079	998.02	941.15	792.43
Other Amortization	106.06	66.65	63.92	60.96	62.16
Loss (Gain) From Sale of Assets	-0.35	2.16	-0.69	1.92	6.82
Loss (Gain) on Equity Investments	-48.18	-20.21	-45.27	-22.78	-1.19
Stock-Based Compensation	35.34	28.75	24.23	20.82	18.58
Provision & Write-off of Bad Debts	3.54	5.58	1.63	4.79	6.54
Other Operating Activities	-37.82	-40.88	39.24	31.24	52.71
Change in Accounts Receivable	-497.46	-590.41	-148.49	-374.61	-186.77
Change in Inventory	-1.34	-742.62	-802.7	-578.18	66.43
Change in Accounts Payable	663.92	397.25	712.36	223.84	115.94
Change in Other Net Operating Assets	-39.3	12.04	63.48	10.58	49.05
Operating Cash Flow	2,317	1,377	1,890	1,320	1,836
Operating Cash Flow Growth	68.30%	-27.17%	43.20%	-28.11%	57.80%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Capital Expenditures	-1,104	-1,402	-1,027	-1,090	-377.27
Sale of Property, Plant & Equipment	14.88	37.17	17.1	22.81	8.31
Cash Acquisitions	-212.48	-155.94	-55.18	-43.53	-265.75
Divestitures	-	-	-	-1.19	-
Investment in Securities	29.35	28.1	31.45	21.21	-160.85
Investing Cash Flow	-1,227	-1,497	-1,065	-1,091	-795.56

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Long-Term Debt Issued	628.9	1,372	1,201	1,317	536.53
Long-Term Debt Repaid	-1,541	-1,525	-1,329	-1,491	-941.66
Net Debt Issued (Repaid)	-912.13	-152.78	-127.99	-174.63	-405.13
Repurchase of Common Stock	-60.43	-32.6	-65.49	-28.53	-12.17
Common Dividends Paid	-524.22	-471.99	-424.33	-466.01	-458.57
Other Financing Activities	-22.01	10.75	-14.03	-	-27.31
Financing Cash Flow	-1,519	-646.63	-631.83	-669.16	-903.17

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Foreign Exchange Rate Adjustments	-5.46	1.44	-0.24	-1.17	7.62
Net Cash Flow	-434.68	-765.51	193.4	-441.02	145.04

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Free Cash Flow	1,213	-25.46	863.11	230	1,459
Free Cash Flow Growth	-	-	275.26%	-84.23%	91.36%
Free Cash Flow Margin	2.83%	-0.07%	2.38%	0.70%	4.80%
Free Cash Flow Per Share	1.41	-0.03	1.01	0.27	1.70
Levered Free Cash Flow	1,137	-153.38	725.14	149.96	1,413
Unlevered Free Cash Flow	1,484	172.24	1,017	381.49	1,616

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Cash Interest Paid	559.64	515.52	457.38	363.36	330.96
Cash Income Tax Paid	401.87	430.65	381.61	381.31	301.07
Change in Working Capital	125.82	-923.75	-175.35	-718.37	44.64

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 18, 2026

Data Sources Report a data error